Diane Provencher
Centre Hospitalier de l’Université de Montréal(CA)Université de Montréal(CA)
Publications by Year
Research Areas
Ovarian cancer diagnosis and treatment, PARP inhibition in cancer therapy, Endometrial and Cervical Cancer Treatments, BRCA gene mutations in cancer, Cancer Genomics and Diagnostics
Most-Cited Works
- → Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial(2017)1,842 cited
- → Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial(2017)1,678 cited
- → ARID1A Mutations in Endometriosis-Associated Ovarian Carcinomas(2010)1,667 cited
- → Antitumor activity and safety of pembrolizumab in patients with advanced recurrent ovarian cancer: results from the phase II KEYNOTE-100 study(2019)800 cited
- → Mutation of FOXL2 in Granulosa-Cell Tumors of the Ovary(2009)765 cited
- → Oral Contraceptives and the Risk of Hereditary Ovarian Cancer(1998)